TransMedics Group’s (TMDX) “Overweight” Rating Reiterated at Piper Sandler
Piper Sandler reaffirmed their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a report issued on Tuesday morning,Benzinga reports. Piper Sandler currently has a $105.00 target price on the stock, up from their prior target price of $90.00. TMDX has been the subject of a number of other reports. Needham & […]
Piper Sandler reaffirmed their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a report issued on Tuesday morning,Benzinga reports. Piper Sandler currently has a $105.00 target price on the stock, up from their prior target price of $90.00. TMDX has been the subject of a number of other reports. Needham & […]
